Results 11 to 20 of about 242 (180)

SYNTHESIS AND DIURETIC ACTIVITY OF 2-(5-(PHENOXYMETHYL)-4-R1-1,2,4-TRIAZOLE-3-YLTHIO)ACETIC ACIDS AND THEIR SALTS [PDF]

open access: yesZaporožskij Medicinskij Žurnal, 2014
It is known that drugs based on the 1,2,4-triazole have a wide spectrum of biological activities. They are effective cardioprotectors, hepatoprotectors, anti-oxidants, which are widely used in cardiology practice.
Yu. N. Kucheryavyi   +2 more
doaj   +2 more sources

Yacton and mexicor influence on prooxidant-antioxidant homeostasis and protein synthesis in the myocardium of rats in conditions of doxorubicin cardiomyopathy

open access: yesZaporožskij Medicinskij Žurnal, 2015
Doxorubicin, which is included in the scheme of cancer treatment, possesses cardiotoxicity that requires effective cardioprotectors searching. Aim.
E. A. Raketskaya   +2 more
doaj   +2 more sources

Growth hormone-releasing peptides and the heart: secretagogues or cardioprotectors? [PDF]

open access: yesCardiovascular Research, 2004
See article by Iwase et al. [13] in this issue. Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) are multifunctional hormones with potent cardiotropic effects in prenatal and postnatal cardiac development. Evidence from animal and clinical studies has documented the beneficial effects of the GH-IGF-1 axis on cardiac hypertrophy and ...
P Lucchesi
openaire   +3 more sources

Place of tiotriazoline in the gallery of modern metabolitotropic medicines [PDF]

open access: yesZaporožskij Medicinskij Žurnal, 2019
We want to show pharmacological characterization of Tiotriazoline, based on results of tentative analysis and clinical research, also features of its therapeutic action and advantage over another metabolitotropic cardio protectors.
I. F. Bielenichev   +3 more
doaj   +2 more sources

Lipid peroxidation and protective antioxidant systems in coronary bypass surgery and cardioprotective therapy

open access: yesРоссийский кардиологический журнал, 2005
Оn-pump coronary bypass surgery was performed in 58 stable angina patients aged 43-72. Group I (n = 19) received standard coronary heart disease (CHD) treatment, together with mildronate: before the surgery, 750 mg/d for 3 days, then 750 mg/d twice a ...
I. G. Gordeev   +5 more
doaj   +1 more source

MAIN DIRECTIONS OF DEVELOPMENTOF ANTI-AGGREGANTS AND CARDIOPROTECTORS [PDF]

open access: yesСовременные проблемы науки и образования (Modern Problems of Science and Education), 2021
T.A. Abzalilov   +3 more
openaire   +2 more sources

Influence of cardioprotectors mildronate and trimetazidine on MB-creatinkinase activity in stable angina patients after coronary bypass surgery

open access: yesРоссийский кардиологический журнал, 2004
.
I. G. Gordeev   +4 more
doaj   +1 more source

MOLECULAR MECHANISMS OF CORRECTION OF CARDIOTOXIC EFFECTS OF ANTHRACYCLINS BY CARDIOPROTECTORS [PDF]

open access: yesСовременные проблемы науки и образования (Modern Problems of Science and Education), 2020
N.V. Tursunova   +3 more
openaire   +2 more sources

Tackling Atherosclerosis via Selected Nutrition. [PDF]

open access: yesInt J Mol Sci, 2022
The development and pathogenesis of atherosclerosis are significantly influenced by lifestyle, particularly nutrition. The modern level of science and technology development promote personalized nutrition as an efficient preventive measure against ...
Vesnina A   +4 more
europepmc   +2 more sources

Ischemia/Reperfusion Injury: Pathophysiology, Current Clinical Management, and Potential Preventive Approaches. [PDF]

open access: yesMediators Inflamm, 2020
Myocardial ischemia reperfusion syndrome is a complex entity where many inflammatory mediators play different roles, both to enhance myocardial infarction‐derived damage and to heal injury. In such a setting, the establishment of an effective therapy to treat this condition has been elusive, perhaps because the experimental treatments have been ...
Sánchez-Hernández CD   +3 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy